Who
Abhay U. Nayak
Executive Vice President
Company insider
Files Form 4 as: Executive Vice President, Zoetis.
In numbers
- Trades disclosed
- 32
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Jan 2020
- Last trade
- 9 Oct 2026
- Last filed
- 13 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Oct 2026filed 13 Oct 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,414321.495 at $26.17 | filing |
| 10 Jul 2026filed 14 Jul 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $5,627214.616 at $26.22 | filing |
| 10 Jul 2026filed 14 Jul 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $5,627214.62 at $26.22 | filing |
| 7 Oct 2022filed 11 Oct 2022 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $5,721122.35 at $46.76 | filing |
| 15 Jul 2022filed 19 Jul 2022 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $5,721104.44 at $54.78 | filing |
| 8 Apr 2022filed 12 Apr 2022 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $11K170.51 at $62.20 | filing |
| 30 Mar 2022filed 1 Apr 2022 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $20K339.41 at $59.61 | filing |
| 12 Feb 2022filed 15 Feb 2022 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —289.89 | filing |
| 12 Feb 2022filed 15 Feb 2022 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,000.9 | filing |
| 12 Feb 2022filed 15 Feb 2022 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —289 | filing |
| 12 Feb 2022filed 15 Feb 2022 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code F | $23K116 at $198.87 | filing |
| 12 Feb 2022filed 15 Feb 2022 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —1,000 | filing |
| 12 Feb 2022filed 15 Feb 2022 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code F | $73K367 at $198.87 | filing |
| 8 Feb 2022filed 10 Feb 2022 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,000.9 at $0.00 | filing |
| 8 Feb 2022filed 10 Feb 2022 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —717 at $0.00 | filing |
| 8 Feb 2022filed 10 Feb 2022 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —2,823 at $0.00 | filing |
| 14 Jan 2022filed 19 Jan 2022 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $4,61572.26 at $63.87 | filing |
| 8 Oct 2021filed 12 Oct 2021 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $5,38487.78 at $61.34 | filing |
| 31 Jul 2021filed 18 Aug 2021 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,764.83 | filing |
| 31 Jul 2021filed 18 Aug 2021 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —1,764 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.